Patients and Industry: Starting Our New Life Together in 2023
Society for Participatory Medicine
FEBRUARY 1, 2023
The FDA issued a series of four patient-focused drug development (PFDD) guidance documents which outline how patient co-design needs to successfully happen. This hasn’t been made clear yet due in part to the fourth and final guidance session on clinical outcome assessment data yet to occur in 2023.
Let's personalize your content